The phosphotyrosine phosphatase SHP2 promotes anergy in chronic lymphocytic leukemia

Blood. 2018 Apr 12;131(15):1755-1758. doi: 10.1182/blood-2017-06-788166. Epub 2018 Feb 23.

Authors

Simon Schliffke¹, Sophia Buhs², Sarah Bolz¹, Helwe Gerull², Lisa von Wenserski¹, Kristoffer Riecken³, Boris Fehse³, Peter Nollau², Mascha Binder¹

Affiliations

¹ Department of Oncology and Hematology, Bone Marrow Transplantation with Section Pneumology, Hubertus Wald Tumorzentrum-University Cancer Center Hamburg.
² Research Institute Children's Cancer Center and Department of Pediatric Hematology and Oncology, and.
³ Research Department Cell and Gene Therapy, Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

PMID: 29475960
DOI: 10.1182/blood-2017-06-788166

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Clonal Anergy*
Female
Humans
Leukemia, Lymphocytic, Chronic, B-Cell / immunology*
Male
Neoplasm Proteins / immunology*
Protein Tyrosine Phosphatase, Non-Receptor Type 11 / immunology*

Substances

Neoplasm Proteins
Protein Tyrosine Phosphatase, Non-Receptor Type 11